Search for: "U.S. v. Lang*" Results 61 - 80 of 15,259
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
11 Apr 2024, 5:59 pm by Jason Rantanen
It would be simpler for a patent holder to just use the U.S. patent to cover foreign activity. [read post]
8 Apr 2024, 5:08 pm by Dennis Crouch
General Electric Co., 283 U.S. 664 (1931), amended, 284 U.S. 571 (1931). [read post]
7 Apr 2024, 2:07 pm by Larry
Such is the case in Ninestar Corporation et al. v. [read post]
7 Apr 2024, 9:19 am
The transformation becomes decisive as language, standards, and operations become opaque to non-specialists and extra-administrative accountability weakens. [read post]
5 Apr 2024, 6:05 am by George Croner
” While the Second Circuit noted in its decision in U.S. v. [read post]
4 Apr 2024, 3:38 pm by Stephanie Snyder-Zuasnabar
After rejecting an offer of additional compensation as inadequate, Olympus filed suit in the U.S. [read post]